The Marcus Corporation filings document a Wisconsin public company with two operating divisions: Marcus Theatres and Marcus Hotels & Resorts. Form 8-K reports furnish quarterly and annual results, including theatre box-office activity, film-slate effects, hotel RevPAR, food-and-beverage operations and share repurchase authorization. Other 8-K disclosures record division leadership succession and board composition changes.
Proxy materials cover shareholder voting, director elections, board structure, executive compensation and related governance disclosures. The filing record also reflects capital-allocation matters and formal reporting around a business model that combines movie theatre operations, hospitality management and significant company-owned real estate assets.
Michael Reade Evans, President of Marcus Hotels & Resorts at The Marcus Corporation (NYSE: MCS), reported significant securities transactions on June 5, 2025. Evans disposed of 934.7367 shares of common stock at $8.2592 per share from his 401(k) Plan, reducing his indirect holdings to zero while maintaining 50,342 shares held directly.
The filing also reveals Evans' substantial options portfolio consisting of:
- 147,623 total stock options with various strike prices ranging from $12.71 to $31.11
- Exercise dates spanning from January 2030 to March 2033
- Vesting schedule: 50% after 2 years, 75% after 3 years, and 100% after 4 years from grant date
This Form 4 filing indicates a partial divestment of Evans' indirect holdings while maintaining significant direct equity ownership and long-term incentive compensation through stock options, suggesting continued alignment with shareholder interests.
This Form 3/A is an amended initial statement of beneficial ownership for Michael Reade Evans, who serves as President of Marcus Hotels & Resorts at The Marcus Corporation (NYSE: MCS). The amendment was filed on June 28, 2025, updating the original Form 3 from August 14, 2023.
Key holdings include:
- Direct Common Stock: 11,534 shares total through various restricted stock grants vesting between 2020-2023
- Indirect Holdings: 936.8786 shares through 401(k) Plan (newly reported in this amendment)
- Stock Options: Total of 147,623 shares underlying options with exercise prices ranging from $12.71 to $31.11 and expiration dates from 2030 to 2033
The restricted stock grants follow a consistent vesting schedule: 50% after 2 years and 100% after 4 years from grant date. Stock options vest similarly: 50% after 2 years, 75% after 3 years, and 100% after 4 years.